MedPath
NMPA Approval

Telmisartan Tablets

国药准字H20050503

November 3, 2021

国药准字H20050503

Drug Information

替米沙坦片

曲亚

曲亚

片剂

40mg

化学药品

November 3, 2021

Company Information

Applicant Company

博山经济开发区岜山村

Manufacturing Company

淄博市博山经济技术开发区

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.

替米沙坦片 - NMPA 批准文号 | MedPath